In classic Hodgkin’s lymphoma (cHL), the common copy number gain of chromosome 9p24.1 leads to the upregulation of PD-L1 expression on Reed-Sternberg cells, prompting the systematic development of PD-1 checkpoint inhibitors in hematologic malignancies (23). This evidence concerns the gene CD274 and hematologic disorder.